No Data
Express News | Halozyme Announces Takeda Received Regulatory Approval for Hyqvia® 10% Subcutaneous Injection Set With Enhanze® in Japan for Patients With Agammaglobulinemia or Hypogammaglobulinemia
Express News | Halozyme Announces argenx's Vydura With Enhanze® Was Granted Regulatory Approval in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
Halozyme and Bristol Myers Squibb Secure FDA Nod for Opdivo Qvantig
Express News | Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ With Enhanze® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (Nivolumab) Indications
Bristol-Myers Gets FDA Okay for Injectable Opdivo
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
